Mediar Therapeutics, Inc. — Form D/A
Mediar Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D amendment with the SEC on 2024-10-22. The offering totals $85.0M, of which $85.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-10-22
- Form: D/A
- Accession: 0001766784-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $85.0M
- Amount sold: $85.0M
- Investors: 17
- Date of first sale: 2022-11-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-466474
Issuer
- Name: Mediar Therapeutics, Inc.
- CIK: 0001766784
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 20 OVERLAND STREET, BOSTON, MA, 02215
- Phone: 617-936-0960
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Michael Baran | Director | New York, NY |
| Meredith Fisher | Director | Half Moon Bay, CA |
| Anja Konig | Director | Boston, MA |
| Andreas Jurgeit | Director | Boston, MA |
| Bharat Srinivasa | Director | Boston, MA |
| Allan Marchington | Director | Boston, MA |
| Rahul Ballal | Director | Boston, MA |
| Rahul Ballal | Executive Officer | Boston, MA |
| Cassidy Blundell | Director | Boston, MA |
| Maina Bhaman | Director | Boston, MA |
| Adam Cotton | Director | Boston, MA |
| Simon Sturge | Director | Boston, MA |
| Marie-Claire Peakman | Director | Boston, MA |
| Meredith Fisher | Executive Officer | Half Moon Bay, CA |
| Nandita Shangari | Director | Boston, MA |
| Peter Parker | Director | Boston, MA |
| David de Graaf | Director | Newton, MA |
| Brian Hubbard | Director | San Diego, CA |
| Stacey Brenner | Executive Officer | Cambridge, MA |
Other filings by this issuer (4)
More